Keynesian economists are annoying enough when they are pitching inflated financial assets on Wall Street or the supposed curative powers of fiscal deficits on Capitol Hill. But they become positively dangerous when they populate the Eccles Building and usurp control of the nation’s capital and money markets lock, stock and barrel in the name of “monetary…
Yesterday had looked like markets were about to kickstart a move lower, but today put paid to that. Today has the appearance of panic buying, with traders not wanting to be left out of any opportunity to ‘buy the dip’. The Dow went as far as to finish with a new closing high. Looking at…
Thomas Drolet has decades of experience in capitalizing on the movement of international energy markets. The chief of Drolet & Associates Energy Services is not sanguine about the long-term potential of fracking, but in this interview with The Mining Report, he tells us why now is a great time to reinvest in the uranium space. The Mining Report: It’s been…
As the data predicted a few weeks ago the Temp Staffing Index has continued on to all time high levels hitting 107 for the week ending 11/23. This bodes very, very well for continued NFP gains through Q1 and into Q2 2015. Also, auto sales remain strong….another indicator of increasing employment:
“When bad men combine, the good must associate; else they will fall one by one, an unpitied sacrifice in a contemptible struggle.” – Edmund Burke In general, I try to apply the maxim that one ought never to attribute to bad intent what can more easily be attributed to well-intentioned stupidity. I bring this up…
The relationship between Russia and the West is not getting any better. Recently Putin returned early from the G20 summit where he was criticized multiple times and it quickly became clear that the president of Russia was not going to sit around and take it. It feels like the arguments are not getting resolved at…
Histogenics (HSGX) may finally deliver an engineered cartilage that can make damaged knees good again. There are a range of new alternatives being developed but the positioning of Histogenics and their “NeoCart” is encouraging. They are enrolling patients for a Phase 3 trial for knee defects. [See the HSGX IPO roadshow slides for the full story.] At…
Call me a perma-bear with these charts. Call me what ever you want. But I do not invent the data, I just look at it and post it when I think it is relevant. There is a post at the GaveKal blog (now linked to the left) about liquidity issues in the markets, so I decided to…
Yesterday, I discussed the recent slide in oil prices wherein I stated: “For investors long ‘energy’ at the current time, oil prices are indeed extremely oversold and are due for a bounce. That ‘bounce’ should likely be used to substantially reduce energy positions in the short term as an increasing amount of data suggests oil prices could go lower.”…
I’ve mentioned this before, but it bears repeating: Tesla (TSLA), having lost over a fifth of its market cap from its high, is vulnerable in two important ways: one, it can’t seem to get its act together with the Model X (which was initially shown years ago, and to this day still isn’t an officially-launched…
